Clinical Trials Sponsored by CHA MEDITECH Co., Ltd.

Total 435 results

CHA MEDITECH Co., Ltd.

Completed

Clinical Study to CMDHA0101 as Compared to PowerFill® for Temporary Penile Enhancement

Penile Enhancement | Small Penis

Korea, Republic of
CHA Vaccine Institute Co., Ltd.

Recruiting

Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above

Herpes Zoster | Vaccine-Preventable Diseases

Korea, Republic of
CHA Vaccine Institute Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine

Hepatitis B, Chronic

Korea, Republic of
CHA Vaccine Institute Co., Ltd.

Completed

A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine

Healthy
CHA Vaccine Institute Co., Ltd.

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine (CVI-HBV-002)

Hepatitis B | Vaccine-Preventable Diseases

Korea, Republic of
CHA Vaccine Institute Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine

Hepatitis B, Chronic

Korea, Republic of
Medtecx Co Ltd.

Completed

Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder Symptoms

Overactive Bladder

China
Asieris MediTech (Hong Kong) Co., Ltd.

Active, not recruiting

Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL) (APRICITY)

Cervical Intraepithelial Neoplasia Grade 2/3

China
CHA University
Medical AI Co., Ltd

Enrolling by invitation

ROMIAE (Rule-Out Acute Myocardial Infarction Using Artificial Intelligence Electrocardiogram Analysis) Trial (ROMIAE)

Myocardial Infarction or Chest Pain

Korea, Republic of
CHA University
Hanlim Pharm. Co., Ltd.

Unknown

Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial

Glaucoma | Ocular Hypertensive

Korea, Republic of
CHA University
Hanlim Pharm. Co., Ltd.

Recruiting

Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients

Glaucoma

Korea, Republic of
CHA University
Boryung Pharmaceutical Co., Ltd

Recruiting

Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab (HCC)

Advanced Hepatocellular Carcinoma

Korea, Republic of
CHA University
Samil Pharmaceutical Co., Ltd.

Completed

Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost

Ocular Hypertension | Glaucoma

Korea, Republic of
CHA University
Hanlim Pharm. Co., Ltd.

Completed

Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive (BCT)

Glaucoma | Ocular Hypertensive

Korea, Republic of
Hangzhou Valgen Medtech Co., Ltd

Not yet recruiting

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

Obstructive Hypertrophic Cardiomyopathy

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's False Lumen Embolization : The First in Man Study of WeFlow-EndoSeal Aorta Vascular Plug System

Aortic Dissection Aneurysm

China
Hangzhou Endonom Medtech Co., Ltd.

Not yet recruiting

A Real World Study on Fabulous® Thoracic Aortic Stent System for Stanford B Aortic Dissection

Aortic Dissection

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Safety and Efficacy Study of WeFlow-JAAA Stent Graft System for Complex Abdominal Aortic Aneurysm(GREAT Study)

Juxtarenal Abdominal Aortic Aneurysm

China
Hangzhou Valgen Medtech Co., Ltd

Enrolling by invitation

Safety and Effectiveness Study of Dragonfly System for Degenerative Mitral Regurgitation

Degenerative Mitral Valve Disease

China
Hangzhou Valgen Medtech Co., Ltd

Recruiting

Feasibility Study of the DragonFly-T System for Severe Tricuspid Regurgitation

Tricuspid Regurgitation

China
Hangzhou Valgen Medtech Co., Ltd

Not yet recruiting

Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation

Tricuspid Regurgitation

China
Jiangsu CED Medtech Co., Ltd

Not yet recruiting

The Flow Diverter for Treating Patients With Intracranial Aneurysms

Intracranial Aneurysm
Hangzhou Valgen Medtech Co., Ltd

Active, not recruiting

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

Obstructive Hypertrophic Cardiomyopathy

China
Hangzhou Endonom Medtech Co., Ltd.

Active, not recruiting

Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study)

Type B Aortic Dissection

China
Hangzhou Endonom Medtech Co., Ltd.

Active, not recruiting

Guo's Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System

Aortic Arch; Aneurysm, Dissecting

China
Hangzhou Valgen Medtech Co., Ltd

Enrolling by invitation

Feasibility Study of Dragonfly System for Severe Tricuspid Regurgitation

Tricuspid Regurgitation

China
Hangzhou Endonom Medtech Co., Ltd.

Unknown

Guo's Visceral Arteries Reconstruction :The First in Man Study of WeFlow-JAAA Stent Graft System

Juxta Renal Abdominal Aortic Aneurysm Without Rupture

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's Aortic Arch Reconstruction: A Multicenter, Prospective Study of the Novel WeFlow-Tribranch System (GENIUS Study)

Aortic Arch Aneurysm

China
Hangzhou Valgen Medtech Co., Ltd

Not yet recruiting

DragonFly EU Pivotal Study

Mitral Valve Insufficiency
Hangzhou Endonom Medtech Co., Ltd.

Not yet recruiting

A Real-World Study on Distal Aortic Remodeling for Stanford Type B Aortic Dissection With Fabulous Thoracic Aortic Stent System

Aortic Dissection

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study(GRAFT Study)

Aortic Aneurysm and Dissection

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)

Aortic Arch Aneurysm

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's Entry Tear Repair :The First in Man Study of Endopatch System

Chronic Stanford B Type Aortic Dissection Proximal Tear

China
Hangzhou Valgen Medtech Co., Ltd

Recruiting

Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation

Mitral Regurgitation Functional

China
Hangzhou Endonom Medtech Co., Ltd.

Completed

Treatment of Vein Stenosis or Occlusion With the Oblique Stent

Iliac Vein Stenosis | Iliac Vein Occlusion

China
Hangzhou Valgen Medtech Co., Ltd

Enrolling by invitation

Dragonfly-M Early Feasibility Study

Mitral Regurgitation

China
Hangzhou Endonom Medtech Co., Ltd.

Completed

Safety and Efficacy Study of Fabulous Stent Graft System for Stanford B Aortic Dissection

Aortic Dissection Type B

China
Hangzhou Valgen Medtech Co., Ltd

Unknown

Safety and Performance Study of the MitralStitch Repair System.

Mitral Regurgitation

China
CHA University
Dong-A ST Co., Ltd.

Unknown

Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients

Chronic Hepatitis B

Korea, Republic of
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Recruiting

A Study to Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer (ANTICIPATE)

Muscle Invasive Bladder Cancer

United States, China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients (ASCERTAIN)

Non-muscle Invasive Bladder Cancer

China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers

Bladder Cancer

Australia
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Recruiting

A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis

United States
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Active, not recruiting

Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients (ACCRUE)

Non-muscle Invasive Bladder Cancer

China
Jiangsu Yahong Meditech Co., Ltd aka Asieris

Completed

Study of Continuous APL-1202 Treatment in Subjects With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Relapsed From Intravesical Chemo/BCG Therapy

Non-muscle Invasive Bladder Cancer
OrbusNeich
CCRC Medtech (Shanghai) Co., Ltd.

Recruiting

Scoreflex TRIO - Scoring PTCA Catheter

Coronary Arteriosclerosis

China
Shanghai MicroPort Rhythm MedTech Co., Ltd.

Recruiting

Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis(CREST)

Coronary Artery Stenosis

China
Shanghai MicroPort Rhythm MedTech Co., Ltd.

Recruiting

Coronary Covered Stents Implantation for the Treatment of Coronary Artery Perforation (CONVOY)

Coronary Artery Perforation

China
Shanghai MicroPort EP MedTech Co., Ltd.

Active, not recruiting

A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia (PSVT)

Paroxysmal Supraventricular Tachycardia

China
Shanghai MicroPort CardioFlow Medtech Co., Ltd.

Unknown

VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial

Aortic Valve Stenosis

China

3

Subscribe